AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 70 filers reported holding AUDENTES THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $75,786,000 | +350.7% | 1,266,506 | +111.5% | 0.01% | +100.0% |
| Q3 2019 | $16,817,000 | -13.5% | 598,705 | +16.6% | 0.00% | -20.0% |
| Q2 2019 | $19,436,000 | +13.5% | 513,384 | +16.9% | 0.01% | +25.0% |
| Q1 2019 | $17,130,000 | +1.9% | 439,030 | -44.3% | 0.00% | +33.3% |
| Q4 2018 | $16,818,000 | +25.8% | 788,910 | +133.7% | 0.00% | -25.0% |
| Q3 2018 | $13,365,000 | +11.1% | 337,599 | +7.2% | 0.00% | 0.0% |
| Q2 2018 | $12,034,000 | +73.9% | 314,950 | +36.8% | 0.00% | +100.0% |
| Q1 2018 | $6,919,000 | +9.5% | 230,250 | +13.9% | 0.00% | 0.0% |
| Q4 2017 | $6,316,000 | +25.9% | 202,124 | +12.9% | 0.00% | 0.0% |
| Q3 2017 | $5,016,000 | +58.2% | 179,083 | +8.0% | 0.00% | +100.0% |
| Q2 2017 | $3,171,000 | +319.4% | 165,783 | +273.2% | 0.00% | – |
| Q1 2017 | $756,000 | -3.3% | 44,420 | +3.7% | 0.00% | – |
| Q4 2016 | $782,000 | +209.1% | 42,829 | +201.0% | 0.00% | – |
| Q3 2016 | $253,000 | – | 14,229 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYQUANT CAPITAL SAS | 767,502 | $45,927,000 | 23.65% |
| Chicago Capital Management, LLC | 250,401 | $14,984,000 | 12.57% |
| Foresite Capital Management III, LLC | 233,067 | $13,947,000 | 7.82% |
| Partner Investment Management, L.P. | 17,795 | $1,065,000 | 7.65% |
| RAMIUS ADVISORS LLC | 220,784 | $13,212,000 | 5.68% |
| Beryl Capital Management LLC | 550,426 | $32,937,000 | 5.31% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 647,460 | $38,744,000 | 5.28% |
| FNY Investment Advisers, LLC | 278,861 | $16,687,000 | 5.17% |
| WHITE SQUARE CAPITAL LLP | 112,500 | $6,732,000 | 4.87% |
| Casdin Capital, LLC | 860,000 | $51,462,000 | 4.73% |